Evaluation of Serum Ages Levels in Patients With Endometriosis

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital (Other)

Overall Status

Completed

CT.gov ID

NCT04886024

Collaborator

(none)

Enrollment

Location

7.8

Actual Duration (Months)

11.6

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Serum AGES (Advanced Glycation End Products) levels of endometriosis patients are compared with a group of healthy volunteers of the same age.

Condition or Disease	Intervention/Treatment	Phase
Endometriosis	Other: Advanced Glycation End Products (AGEs)

Detailed Description

Serum AGES (Advanced Glycation End Products) levels are compared with 45 endometriosis patients and 45 healthy volunteers of the same age. The energy metabolism of the endometriosis group and its possible relationship with the endometriosis stage will be compared since AGES (Advanced Glycation End Products) gives information about the energy metabolism of the people.

Study Design

Study Type:

Observational

Actual Enrollment :

90 participants

Observational Model:

Case-Control

Time Perspective:

Prospective

Official Title:

The Serum Ages Levels in Patients With Endometriosis

Actual Study Start Date :

Dec 5, 2020

Actual Primary Completion Date :

Jul 20, 2021

Actual Study Completion Date :

Jul 30, 2021

Arms and Interventions

Arm	Intervention/Treatment
women with endometriosis It consists of women between the ages of 18-45 who have been diagnosed with endometriosis by surgery or ultrasonography.	Other: Advanced Glycation End Products (AGEs) Advanced Glycation End Products (AGEs) releated with energy metabolism, In this study, the possible relationship between the serum levels of Advanced Glycation End Products (AGEs) of endometriosis patients and the disease and its stage is evaluated.
control It consists of healthy women between the ages of 18-45	Other: Advanced Glycation End Products (AGEs) Advanced Glycation End Products (AGEs) releated with energy metabolism, In this study, the possible relationship between the serum levels of Advanced Glycation End Products (AGEs) of endometriosis patients and the disease and its stage is evaluated.

Arm

Intervention/Treatment

women with endometriosis

It consists of women between the ages of 18-45 who have been diagnosed with endometriosis by surgery or ultrasonography.

Other: Advanced Glycation End Products (AGEs)

Advanced Glycation End Products (AGEs) releated with energy metabolism, In this study, the possible relationship between the serum levels of Advanced Glycation End Products (AGEs) of endometriosis patients and the disease and its stage is evaluated.

control

It consists of healthy women between the ages of 18-45

Other: Advanced Glycation End Products (AGEs)

Outcome Measures

Primary Outcome Measures

Serum Advanced Glycation End Products (AGEs) levels in women with endometriosis [8 months]
Serum Serum Advanced Glycation End Products (AGEs) levels involved in inflammation and energy metabolism are compared between endometriosis and healthy control group

Secondary Outcome Measures

Comparison of the relationship between serum Serum Advanced Glycation End Products (AGEs) level and endometriosis stage [8 months]
By comparing the relation of serum Advanced Glycation End Products (AGEs) level with the stage of endometriosis, its relation with serum level in patients with advanced and early stage endometriosis will be examined. The possible effect of Advanced Glycation End Products (AGEs) on disease pathogenesis will be examined.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 45 Years

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

diagnosed with endometriosis (Surgery or ultrasound)
Women without endometriosis

Exclusion Criteria:

Women without endometriosis women who are only suspected endometriosis

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Pinar Yalcin Bahat	Istanbul	İ̇stanbul	Turkey	34000

Sponsors and Collaborators

Kanuni Sultan Suleyman Training and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Pınar Yalcin bahat, Principal Investigator, Kanuni Sultan Suleyman Training and Research Hospital

ClinicalTrials.gov Identifier:

NCT04886024

Other Study ID Numbers:

endo-serum ages levels

First Posted:

May 13, 2021

Last Update Posted:

Aug 31, 2021

Last Verified:

Aug 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Undecided

Plan to Share IPD:

Undecided

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Pınar Yalcin bahat, Principal Investigator, Kanuni Sultan Suleyman Training and Research Hospital

AGES (Advanced Glycation End Products)

Additional relevant MeSH terms:

Endometriosis

Study Results

No Results Posted as of Aug 31, 2021